Moderna
Agent49Agent Readiness: 49/100. Top 25%. Measured by StartupHub.ai. Median 41.Trust89Data Trust: 89/100. Top 25%. Measured by StartupHub.ai. Median 61.Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
About
Moderna, Inc. is a US biotechnology company that develops mRNA-based vaccines and therapeutics. It gained global prominence with the development of mRNA-1273, one of the first authorized COVID-19 vaccines.
Listed competitors
Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.
A global pharmaceutical and biotechnology corporation developing innovative medicines and vaccines for various therapeutic areas.
Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
Also in this space
Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
Shares Biotechnology, Pharmaceuticals
Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.
Shares Biotechnology, HealthTech
A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.
Shares Biotechnology, Drug Discovery
Advancing next-generation mRNA medicines.
Shares Biotechnology, Pharmaceuticals
Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.
Shares Biotechnology, Pharmaceuticals
AI-driven biotechnology company developing novel protein therapeutics through generative biology.
Shares Biotechnology, Drug Discovery
Key facts
- Website
- modernatx.com
- Headquarters
- Cambridge, United States
- Founded
- 2010
- Employees
- 6,297
- Total funding
- $4.5B (Funding Round)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jun 2026 | Funding Round | $50M | Coalition for Epidemic Preparedness Innovations (CEPI) |
| 1 Dec 2025 | Grant | $54M | |
| 1 Nov 2025 | Post-IPO Debt | $600M | |
| 1 Jul 2024 | Grant | $176M | |
| 1 Mar 2024 | Post-IPO Equity | $750M | Blackstone |
| 1 Oct 2022 | Post-IPO Equity | $250M | |
| 18 May 2020 | Series G | $1.3B | |
| 1 Apr 2020 | Grant | $483M | |
| 1 May 2018 | Series H | $125M | |
| 1 Feb 2018 | Series G | $500M | |
| 1 Jan 2015 | Series E | $100M | |
| 1 Jan 2013 | Series C | $40M |
Tech stack
Detected on modernatx.com and in its job posts, last scanned 31 Oct 2026. Run your own scan
- Frontend
- Next.js
- Backend
- Python
- Auth
- Okta
- CDN
- AWS CloudFront
- Hosting
- AWS, Google Cloud
- Email provider
- Microsoft 365, SendGrid
- Hiring platform
- Workday
- Mobile
- Swift
Moderna scores 80. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
What does Moderna do?
Beyond COVID, Moderna has a pipeline spanning influenza, RSV, HIV, cancer vaccines, and rare disease treatments. The company generated $19 billion in revenue in 2022.
Is Moderna trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Moderna is 89 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Moderna raised?
Moderna has raised a total of $4.5B in funding. The most recent round on record is Funding Round.
How many employees does Moderna have?
Moderna has approximately 6,297 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Moderna
